Vident Advisory, LLC Compugen LTD Transaction History
Vident Advisory, LLC
- $4.8 Trillion
- Q1 2024
A detailed history of Vident Advisory, LLC transactions in Compugen LTD stock. As of the latest transaction made, Vident Advisory, LLC holds 28,658 shares of CGEN stock, worth $44,706. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,658
Previous 30,077
4.72%
Holding current value
$44,706
Previous $59.6 Million
24.16%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CGEN
# of Institutions
80Shares Held
13.7MCall Options Held
131KPut Options Held
76K-
Taylor Frigon Capital Management LLC1.32MShares$2.06 Million1.64% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.3MShares$2.02 Million0.01% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD1.29MShares$2.01 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.04MShares$1.62 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.59 Million0.0% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $135M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...